X, D., H, W., M, Y., Y, H., A, S., W, C., . . . J, M. (2026). Design, synthesis and biological evaluations of novel VEGFR-2 inhibitors based on Fruquintinib and Cabozantinib. Molecular diversity. https://doi.org/10.1007/s11030-026-11628-w
Chicago Style (17th ed.) CitationX, Ding, Wei H, Ye M, Huang Y, Su A, Chen W, Tang Z, and Ma J. "Design, Synthesis and Biological Evaluations of Novel VEGFR-2 Inhibitors Based on Fruquintinib and Cabozantinib." Molecular Diversity 2026. https://doi.org/10.1007/s11030-026-11628-w.
MLA (9th ed.) CitationX, Ding, et al. "Design, Synthesis and Biological Evaluations of Novel VEGFR-2 Inhibitors Based on Fruquintinib and Cabozantinib." Molecular Diversity, 2026, https://doi.org/10.1007/s11030-026-11628-w.
Warning: These citations may not always be 100% accurate.